Search research articles
Contact Us
Filters
Showing results (1-10 of 65) with videos related to
Page
of 7
Sort By:
Expert Opinion on Drug Metabolism & Toxicology
|
August 6, 2008
Advances in the interpretation and prediction of CYP2E1 metabolism from a biochemical perspective
Grover P Miller
Expert Opinion on Drug Metabolism & Toxicology
|
April 13, 2011
Assays and applications in warfarin metabolism: what we know, how we know it and what we need to know
Drew R Jones, Grover P Miller
Toxicology
|
February 25, 2014
Inhibitory potency of 4-carbon alkanes and alkenes toward CYP2E1 activity
Jessica H Hartman, Grover P Miller, Gunnar Boysen
Biochemical Pharmacology
|
December 19, 2013
CYP2E1 hydroxylation of aniline involves negative cooperativity
Jessica H Hartman, Katie Knott, Grover P Miller
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
July 19, 2012
CYP2E1 metabolism of styrene involves allostery
Jessica H Hartman, Gunnar Boysen, Grover P Miller
Xenobiotica; the Fate of Foreign Compounds in Biological Systems
|
January 19, 2013
Cooperative effects for CYP2E1 differ between styrene and its metabolites
Jessica H Hartman, Gunnar Boysen, Grover P Miller
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
|
April 8, 2011
Novel multi-mode ultra performance liquid chromatography-tandem mass spectrometry assay for profiling enantiomeric hydroxywarfarins and warfarin in human plasma
Drew R Jones, Gunnar Boysen, Grover P Miller
Drug Metabolism Reviews
|
October 1, 2009
Warfarin and UDP-glucuronosyltransferases: writing a new chapter of metabolism
Drew R Jones, Jeffery H Moran, Grover P Miller
Toxicology Research
|
October 10, 2017
Toxicological Implications of Mitochondrial Localization of CYP2E1
Jessica H Hartman, Grover P Miller, Joel N Meyer
ACS Central Science
|
May 11, 2016
Modeling Epoxidation of Drug-like Molecules with a Deep Machine Learning Network
Tyler B Hughes, Grover P Miller, S Joshua Swamidass
Page
of 7
Search research articles
Search
Showing results (1-10 of 65) with videos related to
Sort By:
Page
of 7
Expert Opinion on Drug Metabolism & Toxicology
|
August 6, 2008
Advances in the interpretation and prediction of CYP2E1 metabolism from a biochemical perspective
Grover P Miller
Expert Opinion on Drug Metabolism & Toxicology
|
April 13, 2011
Assays and applications in warfarin metabolism: what we know, how we know it and what we need to know
Drew R Jones, Grover P Miller
Toxicology
|
February 25, 2014
Inhibitory potency of 4-carbon alkanes and alkenes toward CYP2E1 activity
Jessica H Hartman, Grover P Miller, Gunnar Boysen
Biochemical Pharmacology
|
December 19, 2013
CYP2E1 hydroxylation of aniline involves negative cooperativity
Jessica H Hartman, Katie Knott, Grover P Miller
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
July 19, 2012
CYP2E1 metabolism of styrene involves allostery
Jessica H Hartman, Gunnar Boysen, Grover P Miller
Xenobiotica; the Fate of Foreign Compounds in Biological Systems
|
January 19, 2013
Cooperative effects for CYP2E1 differ between styrene and its metabolites
Jessica H Hartman, Gunnar Boysen, Grover P Miller
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
|
April 8, 2011
Novel multi-mode ultra performance liquid chromatography-tandem mass spectrometry assay for profiling enantiomeric hydroxywarfarins and warfarin in human plasma
Drew R Jones, Gunnar Boysen, Grover P Miller
Drug Metabolism Reviews
|
October 1, 2009
Warfarin and UDP-glucuronosyltransferases: writing a new chapter of metabolism
Drew R Jones, Jeffery H Moran, Grover P Miller
Toxicology Research
|
October 10, 2017
Toxicological Implications of Mitochondrial Localization of CYP2E1
Jessica H Hartman, Grover P Miller, Joel N Meyer
ACS Central Science
|
May 11, 2016
Modeling Epoxidation of Drug-like Molecules with a Deep Machine Learning Network
Tyler B Hughes, Grover P Miller, S Joshua Swamidass
Page
of 7